Erythema News and Research

RSS

A sudden increase in the number of British cases of Lyme disease

Lyme disease, an infection carried by ticks causes a rash and stiffness in the joints and, if left unchecked, it can affect the central nervous system, causing tingling in hands and feet, or facial palsy. In the worst cases the disease can also affect the heart, liver and spleen and even lead to encephalitis, which can kill.

29 May 2005

Intriguing new data on the spread of the Lyme disease bacteria through the blood stream

The ability to find the Lyme spirochete--the tick-borne agent responsible--in the blood is itself an achievement because existing methods of culturing blood were not sensitive enough to detect its presence until College researchers developed a new technique, which they used in the study.

2 May 2005

Vaccinating mice against Lyme disease could help reduce the risk of transmission of the disease to humans

Vaccinating large populations of white-footed mice against the bacterium that causes Lyme disease could help reduce the risk of transmission of the disease to humans, says a study supported by the National Institute of Allergy and Infectious Diseases (NIAID).

14 Dec 2004

System helps physicians prevent radiation-induced skin injuries to patients

The threading of slender catheters and stents through arteries to deliver treatments to the heart, the brain and elsewhere in the body has produced nothing short of a medical revolution.

4 Dec 2004

Radiance FN/Radiesse injectable implant material appears effective and well tolerated by patients undergoing facial soft tissue augmentation

An article in the July/August issue of the Archives of Facial Plastic Surgery reports that the use of Radiance FN/Radiesse injectable implant material appears effective and well tolerated by patients undergoing facial soft tissue augmentation, and patient satisfaction with treatment is high.

20 Jul 2004

3M granted FDA approval for cream to treat superficial basal cell carcinoma

3M announced today that the U.S. Food and Drug Administration (FDA) has approved the first prescription therapy in nearly a decade for the treatment of superficial basal cell carcinoma (sBCC), a type of nonmelanoma skin cancer.

16 Jul 2004

Treatment helps 26% of black Americans with chronic hepatitis C

Twenty-six percent (26%) of black Americans (BA) with chronic hepatitis C who received treatment with Pegasys plus Copegus (peginterferon alfa-2a plus ribavirin) achieved a sustained virological response (SVR), according to study results published in the June 2004 issue of Hepatology.

1 Jun 2004

Damaged metal halide lamps can cause sunburn

Ever think you could get a nasty sunburn — severe enough to peel — by attending an indoor event? Seems improbable, but it can happen. And it has — three times recently in Middle Tennessee.

19 May 2004